David Underwood

CEO

Hitchin, England, United Kingdom49 yrs 6 mos experience

Most Likely To SwitchHighly Stable

Key Highlights

Founding CEO of Quanticate with extensive leadership experience.
Over 17 years in biostatistics and data management.
Expertise in clinical trials and regulatory submissions.

Stackforce AI infers this person is a leader in the Pharmaceutical and Biostatistics industry.

Contact

david.underwood@quanticate.com LinkedIn

Skills

Core Skills

Pharmaceutical IndustryClinical DevelopmentStatistical ConsultingData ManagementClinical Data ManagementClinical Research

Other Skills

Analyzing and designing Clinical and Medical trialsBiostatisticsBiotechnologyCROCRO ManagementClinical Trial Management System (CTMS)Clinical TrialsCustomer ServiceDesign and analysis of medical/clinical trialsDrug DevelopmentElectronic Data Capture (EDC)Good Clinical Practice (GCP)Life SciencesManagementOncology

About

I am the founding CEO and Chairman of Quanticate. Having previously been the Managing Director for Statwood Ltd for 14 years and taking on the role of chairman for Oxford Pharmaceutical Limited (OPS) in 2002, it was decided in October 2007 to merge the two companies to form Quanticate Ltd. Prior to forming Statwood, I worked for 17 years as a statistician and Global Project Leader for Biostatistics and Data Management at Glaxosmithkline.

Experience

Quanticate

CEO and Chairman

Oct 2007 – Present · 18 yrs 5 mos

Pharmaceutical IndustryClinical Data ManagementClinical TrialsCROClinical DevelopmentCustomer Service+19

Oxford pharmaceutical sciences

Managing Director & Chairman

Jan 2002 – Jan 2007 · 5 yrs

Statwood

2 roles

Managing Director and Chairman

Promoted

Jan 2001 – Jan 2007 · 6 yrs

Managing Partner

Jan 1994 – Jan 2001 · 7 yrs

Smith kline and french laboratories

8 roles

Senior Project Leader in CNS area

Jan 1994 – Jan 1994 · 0 mo

In this position I was responsible for the co-ordination and planning for Statistical and Data Management activities involved in the project area, including a regulatory (FDA) submission due in 1995 consisting of a programme of 3 Phase I and 14 Phase IIb/IIl studies. Responsibility was retained for local UK Phase IV Biometrics area.

Statistical ConsultingData Management

Head of Clinical Data Management Services UK

Promoted

Jan 1991 – Jan 1994 · 3 yrs

Responsible for Clinical Data Management and Statistical activities

Clinical Data ManagementStatistical activities

Manager, Statistical Services

Jan 1990 – Jan 1991 · 1 yr

Manager, Commercial Statistican

Jan 1983 – Jan 1989 · 6 yrs

Design and analysis of medical/clinical trials

Design and analysis of medical/clinical trialsClinical Research

Commercial Statistician

Promoted

Jan 1980 – Jan 1983 · 3 yrs

Responsible for statistical aspects of medical trials, market research, quality control and other commercial areas of the company. Responsible for a department of statisticians.

Statistical aspects of medical trialsStatistical Consulting